Freestone Grove Partners LP bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 27,158 shares of the company’s stock, valued at approximately $3,490,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Legal & General Group Plc bought a new stake in Merck KGaA during the second quarter worth approximately $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Merck KGaA in the second quarter valued at $942,087,000. Caisse de depot et placement du Quebec bought a new position in shares of Merck KGaA in the second quarter valued at $571,582,000. Canada Pension Plan Investment Board acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at $536,694,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at $501,199,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
MKGAF opened at $164.12 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a market cap of $21.21 billion, a PE ratio of 25.06 and a beta of 0.96. The business has a fifty day simple moving average of $163.35 and a 200-day simple moving average of $149.06. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
